Radium chloride radium chloride is weakly paramagnetic with a magnetic susceptibility of 1.05. It also differs from barium chloride by the flame color, which is red as opposed to green for barium chloride. Radium chloride is still used for the initial stages of the separation of radium from barium during the extraction of radium from pitchblende. The large quantities of material involved (tonnes of ore for milligrams of radium) favour this less costly (but less efficient) method over those based on radium bromide or radium chromate (used for the later stages of the separation). It was also used in medicine to produce
Radium Drug Administration in 2013 for use in medicine as a cancer treatment of bone metastasis. The main indication of treatment with Xofigo is the therapy of bony metastases from castration-resistant prostate cancer due to the favourable characteristics of this alpha-emitter radiopharmaceutical. Ra has also been used in experiments concerning therapeutic irradiation, as it is the only reasonably long-lived radium isotope which does not have radon as one of its daughters. Radium is still used today as a radiation source in some industrial radiography devices to check for flawed metallic parts, similarly to X-ray imaging. When mixed with beryllium, radium acts